HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Kubatka Selected Research

Cyclooxygenase 2 (Cyclooxygenase-2)

11/2014Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats.
12/2003Chemoprevention of mammary carcinogenesis in female rats by rofecoxib.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Kubatka Research Topics

Disease

85Neoplasms (Cancer)
09/2022 - 09/2008
36Carcinogenesis
09/2022 - 12/2003
30Breast Neoplasms (Breast Cancer)
06/2022 - 09/2008
13Inflammation (Inflammations)
03/2022 - 02/2018
13Carcinoma (Carcinomatosis)
03/2021 - 10/2014
12Neoplasm Metastasis (Metastasis)
05/2021 - 12/2014
6Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 12/2014
5COVID-19
09/2022 - 01/2021
5Renal Cell Carcinoma (Grawitz Tumor)
08/2020 - 07/2018
4Atherosclerosis
12/2021 - 02/2018
4Cardiovascular Diseases (Cardiovascular Disease)
09/2021 - 06/2016
3Infections
09/2022 - 01/2020
3Hypoxia (Hypoxemia)
01/2021 - 03/2018
3Hepatocellular Carcinoma (Hepatoma)
03/2019 - 12/2014
2Prostatic Neoplasms (Prostate Cancer)
09/2022 - 01/2022
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
04/2022 - 08/2021
2Ischemia
01/2022 - 02/2017
2Brain Neoplasms (Brain Tumor)
01/2022 - 01/2020
2Glioblastoma (Glioblastoma Multiforme)
12/2021 - 05/2021
2Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 07/2017
2Coronary Artery Disease (Coronary Atherosclerosis)
12/2021 - 02/2018
2Ischemic Stroke
12/2021 - 02/2018
2Obesity
09/2021 - 06/2017
2Peripheral Nervous System Diseases (PNS Diseases)
03/2021 - 11/2019
2Glioma (Gliomas)
11/2020 - 01/2020
2Urinary Bladder Neoplasms (Bladder Cancer)
01/2020 - 08/2014
2Triple Negative Breast Neoplasms
01/2020 - 01/2019
2Body Weight (Weight, Body)
06/2017 - 07/2013
1Pre-Eclampsia (Preeclampsia)
08/2022
1Colonic Neoplasms (Colon Cancer)
06/2022

Drug/Important Bio-Agent (IBA)

22PhytochemicalsIBA
09/2022 - 04/2015
17Pharmaceutical PreparationsIBA
12/2021 - 07/2013
13FlavonoidsIBA
08/2022 - 12/2018
12Caspase 3 (Caspase-3)IBA
01/2021 - 07/2013
12Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
04/2019 - 12/2003
10Biomarkers (Surrogate Marker)IBA
03/2022 - 12/2014
9MicroRNAs (MicroRNA)IBA
01/2021 - 05/2017
8MelatoninIBA
06/2021 - 10/2014
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 02/2017
7Transcription Factors (Transcription Factor)IBA
01/2021 - 04/2019
6Biological ProductsIBA
12/2021 - 12/2017
6Proteins (Proteins, Gene)FDA Link
12/2021 - 11/2014
6Metformin (Glucophage)FDA LinkGeneric
01/2021 - 02/2018
6Hypoglycemic Agents (Hypoglycemics)IBA
01/2021 - 09/2010
6CarcinogensIBA
05/2020 - 09/2010
6Antineoplastic Agents (Antineoplastics)IBA
12/2019 - 09/2008
6Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
04/2019 - 07/2013
5AntioxidantsIBA
01/2022 - 01/2017
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2018 - 07/2013
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2020
4EnzymesIBA
01/2022 - 08/2020
4Therapeutic UsesIBA
06/2021 - 07/2017
4ResveratrolIBA
01/2021 - 11/2014
4Matrix Metalloproteinases (MMPs)IBA
01/2021 - 06/2020
4Lysine (L-Lysine)FDA Link
12/2020 - 11/2017
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2020 - 01/2014
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020 - 09/2014
4Pioglitazone (Actos)FDA Link
01/2016 - 09/2010
3CytokinesIBA
12/2021 - 02/2018
3Blood Glucose (Blood Sugar)IBA
01/2021 - 01/2019
3Insulin (Novolin)FDA Link
01/2021 - 06/2017
3calebin-AIBA
01/2021 - 07/2020
3LigandsIBA
10/2020 - 12/2019
3SurvivinIBA
08/2020 - 07/2019
3CalciumIBA
06/2020 - 06/2017
3Messenger RNA (mRNA)IBA
01/2019 - 11/2014
3anthraceneIBA
02/2018 - 09/2014
3Hormones (Hormone)IBA
02/2018 - 10/2014
3Caspase 7IBA
04/2015 - 10/2014
3ThiazolidinedionesIBA
08/2014 - 09/2010
2PolyphenolsIBA
01/2021 - 04/2016
2Lactic Acid (Lactate)FDA LinkGeneric
01/2021 - 09/2020
2Antiviral Agents (Antivirals)IBA
01/2021 - 01/2020
2NF-kappa B (NF-kB)IBA
01/2021 - 01/2021
2Cisplatin (Platino)FDA LinkGeneric
01/2021 - 05/2020
2Circular RNAIBA
01/2021 - 01/2020
2Epithelial Cell Adhesion MoleculeIBA
12/2020 - 04/2017
2PowdersIBA
12/2020 - 03/2020
2Carotenoids (Carotene)IBA
12/2020 - 08/2020
2Angiogenesis InhibitorsIBA
12/2020 - 05/2017
2Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2020 - 04/2019
2CaspasesIBA
10/2020 - 12/2014
2Peptides (Polypeptides)IBA
08/2020 - 01/2020
2Histones (Histone)IBA
12/2019 - 05/2019
2InulinFDA Link
06/2016 - 09/2014
2PrebioticsIBA
06/2016 - 09/2014
2oligofructoseIBA
06/2016 - 09/2014
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2014 - 12/2003
1Silybin (Lagosa)IBA
09/2022
1Fluorouracil (Carac)FDA LinkGeneric
06/2022
1Citric Acid (Citrate)FDA LinkGeneric
01/2022
1Tricarboxylic AcidsIBA
01/2022
13-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA
01/2022
1Leucine (L-Leucine)FDA Link
01/2022

Therapy/Procedure

28Therapeutics
09/2022 - 01/2017
8Drug Therapy (Chemotherapy)
09/2022 - 01/2019
8Chemoprevention
05/2020 - 12/2003
6Precision Medicine
03/2022 - 11/2019
6Radiotherapy
12/2021 - 12/2018
1Immunomodulation
04/2022